Vancouver, BC -- (SBWIRE) -- 03/09/2021 -- Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out.

Request For The Sample Copy of this Report At- https://www.emergenresearch.com/request-sample/16

The report also studies the key companies of the Non-Invasive Prenatal Testing market along with analysis of their business strategies, M&A activities, investment plans, product portfolio, financial standing, gross profit margin, and production and manufacturing capacities

Key participants include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.

Method Outlook (Revenue, USD Billion; 2017-2027)
Ultrasound Detection
Biochemical Screening Tests
Cell-free DNA in Maternal Plasma Tests
Others

End-Use Outlook (Revenue, USD Billion; 2017-2027)
Diagnostic Laboratories
Hospitals
Research Centers
Clinics

Application Outlook (Revenue, USD Billion; 2017-2027)
Trisomy
Microdeletion Syndrome
Others

North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019.

Regional Segmentation

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

For more informative information, please visit us @ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

Key Benefits of Buying the Global Non-Invasive Prenatal Testing Report:

Comprehensive analysis of the changing competitive landscape
Assists in decision making processes for the businesses along with detailed strategic planning methodologies
The report offers an 8-year forecast and assessment of the Global Non-Invasive Prenatal Testing Market
Helps in understanding the key product segments and their estimated growth rate
In-depth analysis of market drivers, restraints, trends, and opportunities
Comprehensive regional analysis of the Global Non-Invasive Prenatal Testing Market
Extensive profiling of the key stakeholders of the business sphere
Detailed analysis of the factors influencing the growth of the Global Non-Invasive Prenatal Testing Market

Table of Content

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Indicative Metrics

Chapter 4. Non-Invasive Prenatal Testing Market Segmentation & Impact Analysis

    4.1. Non-Invasive Prenatal Testing Market Product Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. High risk of chromosomal abnormalities with increasing maternal age

                    4.2.2.2. Untapped emerging markets

          4.2.3. Market restraints analysis

                    4.2.3.1. Reliability of test results, especially in obese women

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. ETOP Analysis

    4.6. Porter's Five Forces Analysis

    4.7. Competitive Metric Space Analysis

    4.8. Price trend Analysis

    4.9. Customer Mapping

    4.10. Covid-19 Impact Analysis

    4.11. Global Recession Influence

Chapter 5. Non-Invasive Prenatal Testing Market By Method Insights & Trends

    5.1. Method Dynamics & Market Share, 2020 & 2027

    5.2. Ultrasound Detection

          5.2.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          5.2.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    5.3. Biochemical Screening Tests

          5.3.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          5.3.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    5.4. Cell-free DNA in Maternal Plasma Tests

          5.4.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          5.4.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    5.5. Others

          5.5.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          5.5.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

Chapter 6. Non-Invasive Prenatal Testing Market By End-Use Insights & Trends

    6.1. End-Use Dynamics & Market Share, 2020 & 2027

    6.2. Diagnostic Laboratories

          6.2.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          6.2.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    6.3. Hospitals

          6.3.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          6.3.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    6.4. Research Centers

          6.4.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          6.4.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    6.5. Clinics

          6.5.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          6.5.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

Chapter 7. Non-Invasive Prenatal Testing Market By Application Insights & Trends

    7.1. Application Dynamics & Market Share, 2020 & 2027

    7.2. Trisomy

          7.2.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          7.2.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    7.3. Microdeletion Syndrome

          7.3.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          7.3.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

    7.4. Others

          7.4.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)

          7.4.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

Continue…!

Quick Buy— Non-Invasive Prenatal Testing Market Research Report At: https://www.emergenresearch.com/select-license/16

Thank you for reading our report. To know more about the customization of the report, please get in touch with us, and our team will ensure the report is suited to your requirements.
Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs